-
November 2, 2010 Lupin Announces Litigation Settlement with Forest for Memantine Tablets
-
November 2, 2010 Lupin Announces Final FDA Approval for Suprax® (Cefixime) Chewable Tablets
-
November 1, 2010 Lupin Net Profit up by 34 % in Q2, FY 2010-11 Robust Growth, Strong Profits
-
October 14, 2010 Lupin announces settlement with Warner Chilcott of Loestrin® 24 Fe and Femcon® Fe Patent Litigations
-
October 4, 2010 Lupin Announces Final FDA Approval of Generic Hyzaar® and Cozaar®
-
August 3, 2010 Lupin appoints Paul McGarty as President for Lupin Pharmaceuticals Inc.
-
July 28, 2010 Lupin Net Profit up by 40 % in Q1, FY 2010-11 Consistent Growth, Strong Profits
-
July 1, 2010 Lupin receives FDA approval for Famotidine for Oral Suspension
-
June 4, 2010 Lupin receives FDA approval for Lamotrigine tablets
In this section
Media Contacts
-
Rajalakshmi Azariah
Vice President & Global Head – Corporate Communications